Wnt2b attenuates HSCs activation and liver fibrosis through negative regulating TLR4 signaling

Abstract The Wingless-type MMTV integration site family member 2b (Wnt2b) has been found to be a principal mediator of liver development and regeneration. However, the significance of Wnt2b in the pathogenesis of fibrosis-related liver diseases remains undefined. Here, we report that Wnt2b was highl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yi Yuan, Qiuju Han, Siyu Li, Zhigang Tian, Jian Zhang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f6a27d00a0784ffb91e909997028a95d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f6a27d00a0784ffb91e909997028a95d
record_format dspace
spelling oai:doaj.org-article:f6a27d00a0784ffb91e909997028a95d2021-12-02T15:06:24ZWnt2b attenuates HSCs activation and liver fibrosis through negative regulating TLR4 signaling10.1038/s41598-017-04374-52045-2322https://doaj.org/article/f6a27d00a0784ffb91e909997028a95d2017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-04374-5https://doaj.org/toc/2045-2322Abstract The Wingless-type MMTV integration site family member 2b (Wnt2b) has been found to be a principal mediator of liver development and regeneration. However, the significance of Wnt2b in the pathogenesis of fibrosis-related liver diseases remains undefined. Here, we report that Wnt2b was highly expressed in the fibrotic liver tissues, exhibiting protective effects against activation of hepatic stellate cells (HSCs) and fibrosis progression. We identified a negative regulation of Wnt2b on the toll-like receptor 4 (TLR4) activation-mediated pro-fibrogenic effects. Wnt2b was shown not only to directly suppress LPS-induced HSCs activation, but also to inhibit TLR4-enhanced the sensitivity of HSCs to transforming growth factor beta (TGF-β). Mechanistic study showed that Wnt2b suppresses TLR4 signaling through inhibiting the expression of TLR4 as well as the activation of NF-κB and MAPKs. These findings provided new insights into the pathophysiology of liver fibrosis by characterizing Wnt2b as a novel endogenous suppressor of TLR4 signaling, maintaining tissue homeostasis during the early stage of hepatic fibrosis-associated liver diseases.Yi YuanQiuju HanSiyu LiZhigang TianJian ZhangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yi Yuan
Qiuju Han
Siyu Li
Zhigang Tian
Jian Zhang
Wnt2b attenuates HSCs activation and liver fibrosis through negative regulating TLR4 signaling
description Abstract The Wingless-type MMTV integration site family member 2b (Wnt2b) has been found to be a principal mediator of liver development and regeneration. However, the significance of Wnt2b in the pathogenesis of fibrosis-related liver diseases remains undefined. Here, we report that Wnt2b was highly expressed in the fibrotic liver tissues, exhibiting protective effects against activation of hepatic stellate cells (HSCs) and fibrosis progression. We identified a negative regulation of Wnt2b on the toll-like receptor 4 (TLR4) activation-mediated pro-fibrogenic effects. Wnt2b was shown not only to directly suppress LPS-induced HSCs activation, but also to inhibit TLR4-enhanced the sensitivity of HSCs to transforming growth factor beta (TGF-β). Mechanistic study showed that Wnt2b suppresses TLR4 signaling through inhibiting the expression of TLR4 as well as the activation of NF-κB and MAPKs. These findings provided new insights into the pathophysiology of liver fibrosis by characterizing Wnt2b as a novel endogenous suppressor of TLR4 signaling, maintaining tissue homeostasis during the early stage of hepatic fibrosis-associated liver diseases.
format article
author Yi Yuan
Qiuju Han
Siyu Li
Zhigang Tian
Jian Zhang
author_facet Yi Yuan
Qiuju Han
Siyu Li
Zhigang Tian
Jian Zhang
author_sort Yi Yuan
title Wnt2b attenuates HSCs activation and liver fibrosis through negative regulating TLR4 signaling
title_short Wnt2b attenuates HSCs activation and liver fibrosis through negative regulating TLR4 signaling
title_full Wnt2b attenuates HSCs activation and liver fibrosis through negative regulating TLR4 signaling
title_fullStr Wnt2b attenuates HSCs activation and liver fibrosis through negative regulating TLR4 signaling
title_full_unstemmed Wnt2b attenuates HSCs activation and liver fibrosis through negative regulating TLR4 signaling
title_sort wnt2b attenuates hscs activation and liver fibrosis through negative regulating tlr4 signaling
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/f6a27d00a0784ffb91e909997028a95d
work_keys_str_mv AT yiyuan wnt2battenuateshscsactivationandliverfibrosisthroughnegativeregulatingtlr4signaling
AT qiujuhan wnt2battenuateshscsactivationandliverfibrosisthroughnegativeregulatingtlr4signaling
AT siyuli wnt2battenuateshscsactivationandliverfibrosisthroughnegativeregulatingtlr4signaling
AT zhigangtian wnt2battenuateshscsactivationandliverfibrosisthroughnegativeregulatingtlr4signaling
AT jianzhang wnt2battenuateshscsactivationandliverfibrosisthroughnegativeregulatingtlr4signaling
_version_ 1718388490030284800